In April 2010 AstraZeneca agreed to pay the U.S. government and state Medicaid programs $520 million to settle a lawsuit filed
against it by the Justice Department based on similar charges regarding the company's promotion of several non-approved uses
for Seroquel, including for Alzheimer's, aggressive behaviors, depression, and posttraumatic stress disorder. In agreeing
to that settlement, the company also denied the allegations of illegal activities (Psychiatric News, June 18, 2010). It still faces thousands of civil lawsuits filed by individuals who allege serious adverse effects stemming
from their use of Seroquel.